ISPOR - HTA209 How Do Post-Registration Studies Impact Drug Evaluation by the Transparency Committee?

Full Text

HTA209 How Do Post-Registration Studies Impact Drug Evaluation by the Transparency Committee?

Abstract

Authors

M Marie C de Sauvebeuf D Chavade

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now